Effect of Lidocaine Sprayed on Hemodynamics During Endotracheal Intubation
NCT ID: NCT01737437
Last Updated: 2012-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2012-10-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group L
10% Lidocaine was applied to the laryngoscope blade and 0.9% normal saline was applied to the trachea.
group L
10% Lidocaine was applied to the laryngoscope blade and 0.9% normal saline was applied to the trachea.
group C
0.9% normal saline was applied to trachea and laryngoscope blade in Group C.
group C
0.9% normal saline was applied to trachea and laryngoscope blade
group V
0.9% normal saline was applied to the laryngoscope blade and 10% Lidocaine was applied on trachea.
group V
0.9% normal saline was applied to the laryngoscope blade and 10% Lidocaine was applied on trachea.
group LV
10% Lidocaine was applied on laryngoscope blade and trachea.
group LV
10% Lidocaine was applied on laryngoscope blade and trachea.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
group C
0.9% normal saline was applied to trachea and laryngoscope blade
group L
10% Lidocaine was applied to the laryngoscope blade and 0.9% normal saline was applied to the trachea.
group V
0.9% normal saline was applied to the laryngoscope blade and 10% Lidocaine was applied on trachea.
group LV
10% Lidocaine was applied on laryngoscope blade and trachea.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA groups I or II
Exclusion Criteria
* hypertension,
* anticipated difficult airway, and
* severe coronary and cerebrovascular diseases
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hee-Pyoung Park
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hee-Pyoung PARK, MD PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
php1
Identifier Type: -
Identifier Source: org_study_id